Clinical Trial Update: Changes in Central Arterial Pressure When Comparing Nifedipine/Labetalol for Routine Hypertension Control in Pregnancy

View source ↗

Summary

The clinical trial evaluating changes in central arterial pressure when using nifedipine/labetalol to control hypertension in pregnancy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Nifedipine (nifedipine)
• labetalol (labetalol hydrochloride)

Snippet

Sponsor: St. Louis University | Conditions: Hypertension | Status: WITHDRAWN